Rachel Silverman

Rachel Silverman is a Researcher affiliated with the Department of Statistics at Virginia Tech's College of Science, where she serves as a Research Scientist at the Center for Biostatistics and Health Data Science (CBHDS). Previously, she held roles at Virginia Tech's Virginia-Maryland College of Veterinary Medicine and the University of Washington. Her research focuses on epidemiological methods, infectious diseases, sexually transmitted infections (STIs), maternal health, and mathematical modeling. She holds a PhD in Epidemiology from the University of Washington (2018), an ScM in Epidemiology (Infectious Diseases) from Johns Hopkins University (2011), and a BA in Biochemistry from Oberlin College (2008).

Her work spans diverse areas including HIV/AIDS treatment outcomes, STI prevention strategies, and public health responses to outbreaks like COVID-19. Key projects include analyzing vaccine effectiveness against SARS-CoV-2 variants and evaluating interventions to reduce HIV transmission among marginalized populations. She has contributed to studies on drug resistance in antiretroviral therapy and violence prevention in school settings.

• Education:
• PhD in Epidemiology, University of Washington (2018)
• ScM in Epidemiology (Infectious Diseases), Johns Hopkins University (2011)
• BA in Biochemistry, Oberlin College (2008)

Her recent publications emphasize cross-sectional surveys on public health messaging, mixed-methods investigations into youth behavior, and modeling approaches to inform HIV/STI prevention. She collaborates with institutions like the Centers for Disease Control and international health organizations to address global health challenges. Her research integrates biostatistical methods with real-world public health applications.

Dr. Silverman’s work is supported by affiliations with Virginia Tech’s CBHDS and prior roles at the University of Washington’s Department of Global Health and the Maryland Department of Health.